1. Genetic profile and characterization of antimicrobial resistance in Acinetobacter baumannii post-COVID-19 pandemic: a study in a tertiary hospital in Recife, Brazil.
- Author
-
Rocha, Igor Vasconcelos, Martins, Lamartine Rodrigues, Pimentel, Maria Izabely Silva, Mendes, Renata Pessôa Germano, and Lopes, Ana Catarina de Souza
- Subjects
GENETIC profile ,DRUG resistance in microorganisms ,ACINETOBACTER baumannii ,COVID-19 pandemic ,ANTIMICROBIAL stewardship - Abstract
Aims To investigate the genetic profile and characterize antimicrobial resistance, including the main β-lactam antibiotic resistance genes, in Acinetobacterbaumannii isolates from a tertiary hospital in Recife-PE, Brazil, in the post-COVID-19 pandemic period. Methods and Results Acinetobacter baumannii isolates were collected between 2023 and 2024 from diverse clinical samples. Antimicrobial resistance testing followed standardized protocols, with β-lactamase-encoding genes detected via PCR and sequencing. Investigation into ISAba1 upstream of bla
OXA -carbapenemase and blaADC genes was also conducted. Genetic diversity was assessed through ERIC-PCR. Among the 78 A. baumannii , widespread resistance to multiple antimicrobials was evident. Various acquired β-lactamase-encoding genes (blaOXA-23,-24,-58,-143 , blaVIM , and blaNDM ) were detected. Furthermore, this is the first report of blaVIM-2 in A. baumannii isolates harboring either the blaOXA-23-like or the blaOXA-143 gene in Brazil. Molecular typing revealed a high genetic heterogeneity among the isolates, and multi-clonal dissemination. Conclusion The accumulation of genetic resistance determinants underscores the necessity for stringent infection control measures and robust antimicrobial stewardship programs to curb multidrug-resistant strains. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF